Health

EU health security: How prepared is Europe for emerging cross-border health threats?

📅 12 June 2025 | 🕓 16:00–18:00 CEST – Hybrid Conference (online and in Brussels) In the wake of the COVID-19 pandemic, the EU has taken major steps to strengthen its health security framework. But with new threats like antimicrobial resistance (AMR), climate-driven disease patterns, and global instability on the rise, is Europe truly ready? Join Euractiv’s hybrid conference to explore how EU policies are evolving to tackle future pandemics and cross-border health emergencies. Experts and policymakers will discuss how to improve preparedness, ensure access to essential medicines, and foster public-private collaboration in the face of growing health challenges. This timely discussion will also examine the role of EU funding, the importance of on-shore manufacturing for medical countermeasures, and how to build a more resilient and responsive health system across member states. 🔗 Register here to be part of the conversation shaping Europe’s health resilience for the future.

Challenge: Precision OTC pediatric pain-relief devices and formulations by Haleon

  Precision OTC pediatric pain-relief devices and formulations About  Haleon is a global consumer health company based in the United Kingdom, with deep expertise in science-led innovation across oral health, pain relief, respiratory, digestive health, and vitamins. The Challenge   The challenge focuses on identifying safe, effective pediatric pain relief solutions tailored to young children (2–12 yrs). It aims to explore:

• Palatable, low-dose oral formats and needle-free delivery systems for rapid, easy relief
• Non-drug or hybrid approaches, including wearables, botanical actives, or smart devices
• Technologies that improve dosing precision, onset time, palatability/acceptance, convenience, safety profile, or caregiver guidance

The ultimate goal is to deliver safe, effective, and accessible over-the-counter pain relief solutions for children, combining low-dose or non-drug approaches with caregiver-friendly design. Reward Successful applicants can receive 6-month funded project, ranging from $25,000 to $100,000, including access to Haleon’s scientific expertise and potential for expanded partnership opportunities based on results. Timeframe

• Deadline for Submitting Proposals: July 31

Who can apply  

• Applicants with TRL 4-9 solutions

How to apply  Application through HALO Platform. Find here all the details and the submission page  The SPIN4EIC consortium is not responsible for the challenges launched by private or public buyers. Each participating entity is solely responsible for its own challenge, including the selection process, communication with applicants, and all information provided to participants.